OncoNano Medicine

0 followers


OncoNano Medicine is developing a new class of pH-activated compounds that digitalize and exploit the variability of pH in disease. pH variability is a proven, simple, and effective identifier of diseased tissue providing a foundation for the development of a broad range of highly targeted therapeut... Read more

Industries

Employees

11-50

Links

Org chart

Kartik Krishnan
Chief Executive Officer
Kathy Rath
VP, Regulatory Affairs
Ruolan Han
Vice President, Nonclinical And Translational Research
Tian Zhao
Vice President, R&d
Angie Haar
Director Of Operations And Planning
Bhargavi Allu
Sr.analytical Chemist